z-logo
open-access-imgOpen Access
Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland
Author(s) -
Michał Terlecki,
Wiktoria Wojciechowska,
Marek Klocek,
Agnieszka Olszanecka,
Katarzyna StolarzSkrzypek,
Tomasz Grodzicki,
Maciej T. Małecki,
Barbara Katra,
Aleksander Garlicki,
Monika BociągaJasik,
Krzysztof Sładek,
Andrzej Matyja,
Jerzy Wordliczek,
Agnieszka Słowik,
Tomasz Mach,
Katarzyna Krzanowska,
Marcin Krzanowski,
Paweł Stręk,
Piotr Chłosta,
Piotr Hydzik,
Mariusz Korkosz,
T Popiela,
Maciej Pilecki,
Artur Gądek,
Marek Rajzer
Publication year - 2021
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.15990
Subject(s) - medicine , interquartile range , diabetes mellitus , odds ratio , atrial fibrillation , heart failure , coronary artery disease , cardiology , endocrinology
The coronavirus disease 19 (COVID-19) recently became one of the leading causes of death worldwide, similar to cardiovascular disease (CVD). Coexisting CVD may influence the prognosis of patients with COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom